Breast cancer is one of the most common malignant neoplasms in women, but its treatment is becoming more varied and effective as medical technology advances. The five-year survival rate for early breast cancer is high, so early detection, diagnosis and treatment are essential.
Surgery is a key part of breast cancer treatment. The most common methods of surgery include breast cancer modification of the roots, the removal of the lymph nodes of the side breast and the armpit, and breast protection, which removes only the tumor and parts of the surrounding tissue and preserves the appearance of the breast, subject to after the surgery, and after treatment. Doctors make a comprehensive selection of the procedure, depending on the size of the tumor, location, and condition of the patient.
Rehabilitation is the use of high-energy rays to kill cancer cells, which can be performed after surgery to eliminate residual cancer cells and reduce the risk of local recurrence. At the time of the treatment, patients are required to visit the hospital on a regular basis for treatment, which may be characterized by fatigue, red skin, etc., but usually abated after the treatment has ended.
By using chemical drugs to stop the growth and spread of cancer cells, chemotherapy can reduce the size of tumours before the operation, give patients who could not otherwise be operated on the opportunity to operate, and also remove potentially transferred cancer cells after the operation. Chemical drugs are mostly injected into the body by intravenous injection, usually over multiple cycles, with a certain interval in each cycle. Side effects such as nausea, vomiting and hair can occur during chemotherapy, but modern medicine can be mitigated in a variety of ways.
Endocrine treatment is applied to hormonal receptor-positive breast cancer patients, where the growth of cancer cells is inhibited by drug inhibition of estrogen or reduction of estrogen levels. Patients are required to take medication on a daily basis, usually for longer periods of time, with periodic review, monitoring of adverse drug responses and adjustment of treatment programmes.
Target-oriented treatment has become a new trend in recent years, with specific targets for cancer cells working with high accuracy and low side effects. Drugs commonly used, such as tuto-ju, stand alone and have a significant effect on HeR-2 positive breast cancer patients. Genetic tests are required prior to the use of the target for the drug to determine if the target is present, and changes in indicators such as heart function need to be followed closely during the treatment.
Breast cancer treatment is an integrated and individualized process, and patients should actively cooperate with doctors and choose their own treatment. At the same time, maintaining optimism and healthy lifestyles also contributes to improving the effectiveness of treatment and the quality of life.
Breast cancer
